Log In
Print
BCIQ
Print
Print this Print this
 

ADXS-cHER2 (ADXS31-164) (formerly Lovaxin B)

  Manage Alerts
Collapse Summary General Information
Company Advaxis Inc.
DescriptionLive attenuated Listeria monocytogenes vaccine targeting HER2
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today